SDI Limited (ASX:SDI)
Australia · Delayed Price · Currency is AUD 1.255
0.00 (0.00%)
At close: Mar 13, 2026
SDI Limited Revenue
SDI Limited had revenue of 52.93M AUD in the half year ending December 31, 2025, with 1.31% growth. This brings the company's revenue in the last twelve months to 111.77M, up 1.15% year-over-year. In the fiscal year ending June 30, 2025, SDI Limited had annual revenue of 110.38M, down -0.74%.
Revenue (ttm)
111.77M
Revenue Growth
+1.15%
P/S Ratio
1.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
149.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 110.38M | -822.00K | -0.74% |
| Jun 30, 2024 | 111.21M | 3.35M | 3.11% |
| Jun 30, 2023 | 107.86M | 12.70M | 13.35% |
| Jun 30, 2022 | 95.15M | 13.50M | 16.54% |
| Jun 30, 2021 | 81.65M | 14.27M | 21.18% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.10B |
| Sigma Healthcare | 9.55B |
| Cochlear | 2.34B |
| Pro Medicus | 240.57M |
| SomnoMed | 118.50M |
| Vita Life Sciences | 93.27M |
| Austco Healthcare | 92.73M |
| Actinogen Medical | 7.36M |
SDI Limited News
- 3 months ago - SDI Limited (SDLDF) Shareholder/Analyst Call Transcript - Seeking Alpha
- 1 year ago - SDI Ltd (ASX:SDI) (Q1 2025) Earnings Call Highlights: Strong Margins and Market Growth Amid ... - GuruFocus